Accelerating freeze drying cycle development with just seven vials
Compared with other small-scale R&D freeze dryers, the LyoCapsule lyophilizer is the only system that can monitor and independently control the wall temperature via use of the center vial product temperature.
SP Scientific announces the LyoCapsuleFreeze Dryer - an exciting new lyophilization instrument that delivers results comparable to larger R&D freeze dryers enabling a Quality by Design (QbD) approach to cycle development even when materials are highly expensive or limited in quantity. This addition aligns with SP’s mission to provide ‘line of sight’ scale-up equipment and technology from R&D through to commercial freeze drying.
The LyoCapsule freeze dryer's small chamber incorporates a unique cylindrical inner chamber, or ‘capsule,’ to hold the vials and utilizes wall temperature control to ensure that edge vials dry under the same process conditions as center vial. Employing this technology, this mini freeze dryer can be used to mimic the performance of a larger development freeze dryer, utilizing small quantities of costly materials, such as developmental biological drugs and requires far less material preparation time, while still facilitating robust and cost-effective cycle development.
The LyoCapsule freeze dryer may be used to reliably screen formulations for freeze drying feasibility, optimize the freeze drying cycle during development, evaluate efficient process scale-up and much more without requiring the use of large quantities of materials and undue sample preparation time. The unit can accommodate 2 mL to 20 mL vials; seven 20 mL vials can fit comfortably on the circular shelf.
Compared with other small-scale R&D freeze dryers, SP’s LyoCapsule lyophilizer is the only system that can monitor and independently control the wall temperature via use of the center vial product temperature. Utilizing the center vial product temperature enables better control and replication of center vial drying behavior during cycle development. Additionally, vials in the LyoCapsule freeze dryer are in direct contact with the shelf surface replicating the same conditions that are found in larger freeze dryers. A full suite of Process Analytical Technologies (PAT) tools further complements SP Scientific’s ‘line of sight’ scale up as the technologies are available at all freeze dryer scales including production.
In addition, the LyoCapsule freeze dryer offers the user robust process monitoring tools including chamber and condenser capacitance manometers, Pirani gauge, product thermocouples, SMART Freeze Drying technology and TDLAS as an add-on option.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.